Literature DB >> 6285242

[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy].

R J Haas, F J Helmig, H Hausner, R Eife, K Devens, G E Janka, M Helmig, F Lampert.   

Abstract

78 children with Wilms' tumor stage I--IV diagnosed since 1960 are presented. There were two groups of patients: one group consisting of 35 patients which received adjuvant chemotherapy for 1 year, the other group consisting of 43 patients which received no chemotherapy. Surgical excision and irradiation was identical in both groups. The prognosis was greatly improved by adjuvant chemotherapy: 4-year survival rates increased from 25 to 69%. Late side effects from radiation and chemotherapy were noted: 15/78 patients suffered from scoliosis and all patients treated by chemotherapy had a decreased lymphotoxin activity over years. The following factors appear to be related to prognosis: the extent of disease in patients determined by better techniques, histopathology of the tumor, and the nature of treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285242     DOI: 10.1159/000214969

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  1 in total

1.  Control of the carcinogenic potential of 99mTechnetium by the immunologic hormone lymphotoxin.

Authors:  J H Ransom; C H Evans; A E Jones; R A Zoon; J A DiPaolo
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.